Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AATK-AS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | ABCD4 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | ABRACL | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | AC003002.6 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | AC003005.4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AC003006.7 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | AC004076.9 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |